COMMETS- Combination MCI Metabolic Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

COMMETS- Combination MCI Metabolic Syndrome — Stella

Recruiting

Back to Alzheimer Disease trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Israel

Joseph Sagol Neuroscience center, Sheba Medical Center, Ramat Gan

Key details

Phase

Safety & dosing

Sponsor

Rutgers, The State University of New Jersey

Collaborators

Alzheimer's Association

Enrollment target

~80 participants

Started

January 2024

Primary completion

December 2027

Age range

60 Years – 90 Years

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov